Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The correspondence between Scale 2 elevations on the MMPI-2 and
SCID
-diagnosed unipolar depression (major depression and dysthymia) and alcohol-induced
depression
was evaluated among 106 consecutive male admissions to an inpatient alcohol treatment unit. Valid profiles were obtained from 87 subjects, 15% of whom were diagnosed with unipolar depression and another 4.5% with presumed alcohol-induced
depression
. The sensitivity of Scale 2 (the probability that a depressed subject would obtain an elevated score) ranged from .19 to .42. Positive predictive power (the probability that a subject who obtained an elevated score had a depressive disorder) ranged from .23 to .38. Neither Scale 2 alone nor Scale 2 paired in 2-point code types predicted the presence or absence of comorbid depressive disorders among male alcoholics.
...
PMID:The clinical utility of the MMPI-2 in diagnosing unipolar depression among male alcoholics. 833 66
The efficacy and tolerability of moclobemide and sertraline were compared in a 13 week trial on 55 depressive patients. Patients were diagnosed according to DSM-III-R criteria using
SCID
(Structured Clinical Interview for DSM-III-R). The study group was composed of 48 patients with major depression and 7 with minor
depression
. Patients were randomized in two drug groups and raters were blind to the drugs patients used. HDRS and CGI were used to assess the change in depressive symptoms. Twenty seven patients received moclobemide and 28 patients received sertraline. The dose of moclobemide used was 300-600 mg/day and that of sertraline was 50-200 mg/day. At the end of 13 weeks mean drop in HDRS for the overall group was 14.78 and the response rate calculated as percentage of patients showing a 50% drop in HDRS score was 77.8. The response rate was 76.5% for moclobemide and 78.5% for sertraline. The difference was not significant. The side effects were assessed by using UKU Side Effects Rating Scale. The most three observed side effects were dry mouth, headache and insomnia.
...
PMID:Moclobemide and sertraline in the treatment of depressive disorders: a comparative study. 852 56
The relationship between physical attractiveness and symptoms of
depression
was investigated in a general population simple of 1,100 female twins. Photographs were rated by 4 raters. Symptoms of depression were measured by the
Depression
sub-scale of the SCL-54, by a self-rating based on the DSM-III-R, and by an MD diagnosis based on a structured interview (
SCID
). No relationships between ratings of physical attractiveness and symptoms of
depression
were found.
...
PMID:The independence of physical attractiveness and symptoms of depression in a female twin population. 863 8
Mortality from measles is caused mostly by secondary infections associated with the
depression
of cellular immunity. The mechanism of immune suppression and the role of virus strain differences on the immune system are incompletely understood.
SCID
-hu mice were used to determine the effects of virulent, wild-type (Chicago-1) and avirulent, vaccine (Moraten) strains of measles virus (MV) on the human thymus in vivo. Chicago-1 replicated rapidly, with a 100-fold decrease in numbers of thymocytes, whereas Moraten replicated slowly, without significant thymocyte death. Productive MV infection occurred not in thymocytes but in thymic epithelial and myelomonocytic cells. Wild-type MV infection of thymic stromata leads to induction of thymocyte apoptosis and may contribute to a long-term alteration of immune responses. The extent of thymic disruption reflects the virulence of the virus, and therefore the
SCID
-hu mouse may serve as the first small animal model for the study of MV pathogenesis.
...
PMID:Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. 864 8
430 patients participating in the DSM-IV field trial receiving a DSM-III-R
SCID
-derived diagnosis of episodic major depression (n = 131), dysthymic disorder (n = 37) and double
depression
(n = 262) completed the social adjustment scale-self-report (Weissman and Bothwell, 1976). Patients with double
depression
demonstrated greater social morbidity than those suffering from episodic major depression or dysthymic disorder (P < 0.05). Significant predictors of high social morbidity in double depressives included severity of symptoms (P < 0.0001), followed by age of onset of first major depression (P < 0.04). Subscale analysis revealed that double depressives were significantly more impaired in work outside the home and in terms of their financial status (P < 0.05).
...
PMID:Social-vocational adjustment in unipolar mood disorders: results of the DSM-IV field trial. 879 Nov 76
The test-retest reliability of the Inventory to Diagnose
Depression
, Lifetime Version (IDDL) was investigated, based on 57 first-degree relatives of probands with major depression. The subjects were first interviewed using the
SCID
, and then the IDDL was administered to them twice at a 1-month interval. The chance-corrected agreement in diagnosing a lifetime history of DSM-III-R major depression was high between the 2 trials of the IDDL (kappa = 0.77), and between the
SCID
and each of the 2 IDDL trials (kappa = 0.75 for the 1 trial, and 0.68 for the 2nd trial). The positiveness on all items except "increased appetite' and "weight gain' was also highly concordant between the 2 trials. These results strongly suggest that time-stable data with sufficient validity for diagnosing a lifetime history of
depression
can be given by using the IDDL.
...
PMID:The test-retest reliability of the inventory to diagnose depression, lifetime version. 881 34
Eighty-seven patients with current episode of
depression
were assessed by the
SCID
-P and subdivided in bipolar depressives (N = 24), unipolar depressives (n = 38) and dysthymics (n = 25). Anxiety disorders comorbidity in these three groups was investigated by means of the
SCID
-P. Panic disorder comorbidity was found in 36.8% of bipolar depressives, 31.4% of unipolar depressives and 13% of dysthymics. Prevalence of obsessive-compulsive disorder was 21.1% in bipolars, 14.3% in unipolars and 8.7% in dysthymics. Generalized anxiety disorder resulted in being much more associated with dysthymia (65.2%) than with bipolar (31.6%) or unipolar depression (37.1%). Social phobia comorbidity was exhibited mainly by unipolars (11.4%), while no cases were detected in the bipolar group. Odds ratios revealed that generalized anxiety disorder is significantly more likely to co-occur with dysthymia. Panic disorder showed a higher trend to be associated with bipolar and unipolar depression. Social phobia was more frequent among unipolar depression.
...
PMID:Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. 910 56
The aim of this study was to investigate the role of personality deviations in the development and relapses of major depression. The study is based on an investigation of an initial sample of 298 psychiatric out-patients, who were re-evaluated after 6 years when the sample included 253 patients.
SCID
-R was used for assessment of possible relapses and new cases, and a logistic regression analysis was used to determine the best prediction of the recurrence of
depression
. Borderline personality disorders and dependency predicted relapses. In addition, borderline personality disorders, together with avoidant personality disorders, predicted the development of new cases. Comorbid clinical syndromes appear to be of no importance. These findings suggest that the comorbidity with personality deviations accounts for the chronicity and poor prognosis in major depression.
...
PMID:Personality and personality disorders predict development and relapses of major depression. 915 Aug 29
We examined the prevalence and correlates of comorbid anxiety disorders in two groups of older depressed patients assessed at the University of Pittsburgh. A total of 336 older outpatients and inpatients with major depression were comprehensively evaluated with several instruments including the Hamilton
Depression
Rating Scale, and either the SADS-L or the
SCID
for DSM-III-R. These patients presented with major depression, associated with a wide range of functional, cognitive, and medical impairment. One-third to one-half of them also presented with severe symptomatic anxiety. However, only a small proportion (less than 5%) met diagnostic criteria for lifetime or current panic, obsessive-compulsive, or phobic disorders. At baseline, lifetime comorbid anxiety disorders were associated with a higher rate of alcoholism and higher symptomatic anxiety. Lifetime comorbid anxiety disorders did not affect the rate of response of
depression
, but they were associated with a higher use of benzodiazepines and a 50% increase in the time outpatients needed to respond. These findings suggest that, even in psychiatric patients with major depression, the lifetime prevalence of anxiety disorders is lower in late life, but that it has important clinical and therapeutic implications.
...
PMID:Comorbid anxiety disorders in late-life depression. 916 Jun 29
The comorbidity between major depression and personality disorders in patients with long-standing work disability at a rehabilitation clinic was investigated. Sixty patients with a somatoform pain disorder and 66 patients with different medical illnesses were assessed by means of a self rating scale for major depression, and the
SCID
screen personality disorder questionnaire. In the total series, 27% of the patients had a diagnosis of major depression and 34.9% had at least one personality disorder. Personality disorders were significantly more common in patients with medical illness than in patients with a somatoform pain disorder. There was a high frequency of comorbidity between major depression and personality disorders, especially borderline and avoidant personality disorders. If this is due to a common pathogenetic mechanism, it could explain why SSRIs are effective in both
depression
and some personality disorders.
...
PMID:Comorbidity of personality disorders and major depression in patients with somatoform pain disorders or medical illnesses with long-standing work disability. 919 58
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>